Teva Pharmaceuticals Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 11,085.0 | 9,408.0 | 8,408.0 |
| Cost of Goods Sold | 5,117.0 | 4,531.0 | 4,149.0 |
| Gross Profit | 5,968.0 | 4,877.0 | 4,259.0 |
| Gross Profit Margin | 53.8% | 51.8% | 50.7% |
| SG&A Expense | 2,511.0 | 1,901.0 | 1,572.0 |
| Depreciation & Amortization | 493.0 | 521.0 | 431.0 |
| Operating Income | 1,145.0 | 2,553.0 | 885.0 |
| Operating Margin | 10.3% | 27.1% | 10.5% |
| Nonoperating Income | (1.0) | (42.0) | 0.0 |
| Nonoperating Expenses | (318.0) | -- | -- |
| Income Before Taxes | 827.0 | 2,353.0 | 706.0 |
| Income Taxes | 185.0 | 397.0 | 155.0 |
| Net Income After Taxes | 642.0 | 1,956.0 | 551.0 |
| Continuing Operations | 635.0 | 1,952.0 | 546.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 635.0 | 1,952.0 | 546.0 |
| Total Net Income | 635.0 | 1,952.0 | 546.0 |
| Net Profit Margin | 5.7% | 20.7% | 6.5% |
| Diluted EPS from Total Net Income ($) | 0.78 | 2.38 | 0.69 |
| Dividends per Share | 0.30 | 0.33 | 0.25 |
© 2009 Morningstar, Inc. Financial Data provided by
